Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders

Neuroscience

Volumn 169, Issue 4, 2010, Pages 1888-1900

  Ramos, K M ^a   Lewis, M T ^a   Morgan, K N ^a   Crysdale, N Y ^a   Kroll, J L ^a   Taylor, F R ^a   Harrison, J A ^a   Sloane, E M ^a   Maier, S F ^a   Watkins, L R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Allodynia; Astrocyte; Hyperalgesia; Multiple sclerosis; Opioid; Spinal cord

Indexed keywords

CEFTRIAXONE; MORPHINE; VESICULAR GLUTAMATE TRANSPORTER 1;

ADULT ANIMAL; ALLERGIC ENCEPHALOMYELITIS; ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFICACY; GLIA; HYPERALGESIA; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NONHUMAN; PARALYSIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; UPREGULATION; WEAKNESS; WESTERN BLOTTING;

EID: 77955430271     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.06.014     Document Type: Article

References (40)

1. Aronica E., Gorter J.A., Rozemuller A.J., Yankaya B., Troost D. Activation of metabotropic glutamate receptor 3 enhances interleukin (IL)-1beta-stimulated release of IL-6 in cultured human astrocytes. Neuroscience 2005, 130:927-933.
2. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
3. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55-63.
4. Chen W., Mahadomrongkul V., Berger U.V., Bassan M., DeSilva T., Tanaka K., Irwin N., Aoki C., Rosenberg P.A. The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons. J Neurosci 2004, 24:1136-1148.
5. Coderre T.J. The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats. Mol Neurobiol 1993, 7:229-246.
6. Danbolt N.C. Glutamate uptake. Prog Neurobiol 2001, 65:1-105.
7. Furness D.N., Dehnes Y., Akhtar A.Q., Rossi D.J., Hamann M., Grutle N.J., Gundersen V., Holmseth S., Lehre K.P., Ullensvang K., Wojewodzic M., Zhou Y., Attwell D., Danbolt N.C. A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2). Neuroscience 2008, 157:80-94.
8. Garrison C.J., Dougherty P.M., Kajander K.C., Carlton S.M. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 1991, 565:1-7.
9. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88.
10. Harvey L.O. Efficient estimation of sensory thresholds. Behav Res Methods Instrum Comput 1986, 18:10.
11. Haugeto O., Ullensvang K., Levy L.M., Chaudhry F.A., Honore T., Nielsen M., Lehre K.P., Danbolt N.C. Brain glutamate transporter proteins form homomultimers. J Biol Chem 1996, 271:27715-27722.
12. Hu Y., Li W., Lu L., Cai J., Xian X., Zhang M., Li Q., Li L. An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats. Pain 2010, 148:284-301.
13. Johnston I.N., Milligan E.D., Wieseler-Frank J., Frank M.G., Zapata V., Campisi J., Langer S., Martin D., Green P., Fleshner M., Leinwand L., Maier S.F., Watkins L.R. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 2004, 24:7353-7365.
14. Kawasaki Y., Zhang L., Cheng J.K., Ji R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008, 28:5189-5194.
15. King T., Ossipov M.H., Vanderah T.W., Porreca F., Lai J. Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance?. Neurosignals 2005, 14:194-205.
16. Letrent S.P., Polli J.W., Humphreys J.E., Pollack G.M., Brouwer K.R., Brouwer K.L. P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells. Biochem Pharmacol 1999, 58:951-957.
17. Liao S.L., Chen C.J. Differential effects of cytokines and redox potential on glutamate uptake in rat cortical glial cultures. Neurosci Lett 2001, 299:113-116.
18. Liu S., Xu G.Y., Johnson K.M., Echetebu C., Ye Z.S., Hulsebosch C.E., McAdoo D.J. Regulation of interleukin-1beta by the interleukin-1 receptor antagonist in the glutamate-injured spinal cord: endogenous neuroprotection. Brain Res 2008, 1231:63-74.
19. Melone M., Bellesi M., Conti F. Synaptic localization of GLT-1a in the rat somatic sensory cortex. Glia 2009, 57:108-117.
20. Melzer N., Meuth S.G., Torres-Salazar D., Bittner S., Zozulya A.L., Weidenfeller C., Kotsiari A., Stangel M., Fahlke C., Wiendl H. A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis. PLoS One 2008, 3:e3149.
21. Milligan E.D., Hinde J.L., Mehmert K.K., Maier S.F., Watkins L.R. A method for increasing the viability of the external portion of lumbar catheters placed in the spinal subarachnoid space of rats. J Neurosci Methods 1999, 90:81-86.
22. Milligan E.D., Mehmert K.K., Hinde J.L., Harvey L.O., Martin D., Tracey K.J., Maier S.F., Watkins L.R. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res 2000, 861:105-116.
23. Ohgoh M., Hanada T., Smith T., Hashimoto T., Ueno M., Yamanishi Y., Watanabe M., Nishizawa Y. Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis. J Neuroimmunol 2002, 125:170-178.
24. Rasmussen BA, Baron DA, Kim JK, Unterwald EM, Rawls SM (in press) beta-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats. Amino Acids, in press.
25. Rawls S.M., Zielinski M., Patel H., Sacavage S., Baron D.A., Patel D. Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation. Drug Alcohol Depend 2010, 107:261-263.
26. Rothstein J.D., Martin L., Levey A.I., Dykes-Hoberg M., Jin L., Wu D., Nash N., Kuncl R.W. Localization of neuronal and glial glutamate transporters. Neuron 1994, 13:713-725.
27. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes Hoberg M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433:73-77.
28. Schmitt A., Asan E., Lesch K.P., Kugler P. A splice variant of glutamate transporter GLT1/EAAT2 expressed in neurons: cloning and localization in rat nervous system. Neuroscience 2002, 109:45-61.
29. Sloane E., Ledeboer A., Seibert W., Coats B., van Strien M., Maier S.F., Johnson K.W., Chavez R., Watkins L.R., Leinwand L., Milligan E.D., Van Dam A.M. Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. Brain Behav Immun 2009, 23:92-100.
30. Smith M.E., Somera F.P., Eng L.F. Immunocytochemical staining for glial fibrillary acidic protein and the metabolism of cytoskeletal proteins in experimental allergic encephalomyelitis. Brain Res 1983, 264:241-253.
31. Song P., Zhao Z.Q. The involvement of glial cells in the development of morphine tolerance. Neurosci Res 2001, 39:281-286.
32. Storch M.K., Stefferl A., Brehm U., Weissert R., Wallstrom E., Kerschensteiner M., Olsson T., Linington C., Lassmann H. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 1998, 8:681-694.
33. Sung B., Lim G., Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci 2003, 23:2899-2910.
34. Taylor D.L., Jones F., Kubota E.S., Pocock J.M. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J Neurosci 2005, 25:2952-2964.
35. Thone-Reineke C., Neumann C., Namsolleck P., Schmerbach K., Krikov M., Schefe J.H., Lucht K., Hortnagl H., Godes M., Muller S., Rumschussel K., Funke-Kaiser H., Villringer A., Steckelings U.M., Unger T. The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke. J Hypertens 2008, 26:2426-2435.
36. Treutwein B., Strasburger H. Fitting the psychometric function. Percept Psychophys 1999, 61:87-106.
37. Wang M., Dong H.J., Gong Z.H. Effects of beta-lactam antibiotics on development of tolerance and dependence to morphine. Yao Xue Xue Bao 2008, 43:1094-1098.
38. Xin W.J., Weng H.R., Dougherty P.M. Plasticity in expression of the glutamate transporters GLT-1 and GLAST in spinal dorsal horn glial cells following partial sciatic nerve ligation. Mol Pain 2009, 5:15.
39. Yamada K., Watanabe M., Shibata T., Nagashima M., Tanaka K., Inoue Y. Glutamate transporter GLT-1 is transiently localized on growing axons of the mouse spinal cord before establishing astrocytic expression. J Neurosci 1998, 18:5706-5713.
40. Zhang H., Xin W., Dougherty P.M. Synaptically evoked glutamate transporter currents in Spinal Dorsal Horn Astrocytes. Mol Pain 2009, 5:36.